Home > Compound List > Product Information
Vancomycin Deuterated HydrochlorideDISCONTINUED_Molecular_structure_CAS_)
Click picture or here to close

Vancomycin Deuterated HydrochlorideDISCONTINUED

Catalog No. V096502 Name Toronto Research Chemicals
CAS Number Website http://www.trc-canada.com
M. F. C66H76Cl3N9O24 Telephone +1 (416) 665-9696
M. W. 1485.71454 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Chembase ID: 179437

SYNONYMS

IUPAC name
(1S,2R,18R,22S,25R,28R,40S)-48-{[(2S,3R,4S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-(carbamoylmethyl)-47,49-dichloro-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid hydrochloride
IUPAC Traditional name
(1S,2R,18R,22S,25R,28R,40S)-48-{[(2S,3R,4S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-(carbamoylmethyl)-47,49-dichloro-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid hydrochloride
Synonyms
Lyphocin Deuterated
Vancocine Deuterated Hydrochloride
Vancor Deuterated
Meek Deuterated
Vancocin Deuterated Hydrochloride
Vancocyn Deuterated

DATABASE IDS

PROPERTIES

Certificate of Analysis Download
MSDS Link Download

DETAILS

Description (English)
Labelled Vancomycin (V096500). Amphoteric glycopeptide antibiotic produced by Streptomyces orientalis discovered in soil. Inhibits bacterial cell wall synthesis by binding to peptidoglycan. Antibacterial.

REFERENCES

  • Marshall, F.J., et al.: J. Med. Chem., 8, 18 (1965)
  • Cunha, B.A., et al.: Med. Clin. North Am., 79, 817 (1965)
  • Li, L., et al.: Ther. Drug Monit., 17, 366 (1965)